Premil inary Program

This scientifi c programme is endorsed by

TCS - ECMO

w w w . p a r i s - t c s e c m o . o r g

Program committee: N. Aissaoui — J.-P. Collet — A. Combes — G. Lebreton — P. Leprince

G. Montalescot — C. Mossadegh — C. Spaulding

©O

VE

RC

OM

E

TCS - ECMO INTERNATIONAL CONGRESS

J U N E 28 -292018 P A R I S

16 RUE JEAN REY 75015

UI

CP

FINAL PROGRAM

2

w

ww

.t

cs

-e

cm

o.o

rg

La Pitié-Salpêtrière Cardiology Institute of Paris is pleased

to welcome you to the 9th International PARIS TCS-ECMO Congress!

This Congress features the latest evidence on temporary organ support devices for advanced cardiac and respiratory failure.

A specifi c congress track is dedicated to Temporary Circulatory Support (TCS) devices, that are increasingly used by interventional cardiologists to treat cardiogenic

shock due to acute myocardial infarction and end-stage cardiac failure.

The congress also provides state-of–the-art discussions on the indications and results of extracorporeal gas exchange techniques (venovenous ECMO and ECCO2R) for acute respiratory failure.

Cardiologists and particularly interventional cardiologists, heart surgeons, pulmonologists, intensivists, emergency physicians, anesthesiologists, respiratory therapists, perfusionnists, nurses will have the unique opportunity to discuss with world key opinion leaders all theoretical

and practical management aspects of these emerging and very promising technologies

We wish you a pleasant Congress!

Logistics organization and registrationOVERCOME

13-15 rue des Sablons, 75116 Paris, France

Ph: +33 (0)1 40 88 97 97 - Fax: +33 (0)1 43 59 76 07 - E-mail: paris-tcsecmo@overcome.fr

TCS - ECMO INTERNATIONAL CONGRESS

TCS - ECMO

3 w w w . t c s - e c m o . o r g

3w w w . t c s - e c m o . o r g

THURSDAY 28 JUNE

09.00 10.30

10.30 11.00

11.0012.30

12.45 13.45

14.00 15.30

15.30 16.00

16.0017.30

ECMONet Session

Cardiogenic shock

2018 updateECCO2R

TCS in the cath-lab

ECMObasics

ARDS

TCS in STEMI patients

with cardiogenic

shock

Ethics

FRIDAY 29 JUNE

09.00 10.30

10.30 11.00

11.0012.30

12.30 13.30

13.45 15.15

15.15 15.45

15.4517.15

TCS/ECMO in specifi c settings

ECMO VVCardiac arrest

and TCS Common Session: Ethical

dilemmas in

ECMO/TCS patients

ComplicationsECMO/TCS organization

My idealECMO

program

Respiratory sessions TCS Cardiac sessions Nurse and perfusionist sessions

w

ww

.t

cs

-e

cm

o.o

rg

K C

offe

e b

reak

K C

offe

e b

reak

K C

offe

e b

reak

K C

offe

e b

reak

L

unch

sym

posi

um

Lun

ch s

ympo

sium

4

THURSDAY 28 JUNE – LIST AND STEPHENSON

09.00 - 10.30 ECMONET SESSION

Chairmen: D. BRODIE, New York - USA – M. SCHMIDT, Paris - FRA

Should ECMONet lead a new trial of VV-ECMO in ARDS patients? N. FERGUSON, Toronto - CAN PRONECMO, a study of early Proning in ECMO patients M. SCHMIDT, Paris - FRA This is how we designed the SUPERNOVA RCT A. COMBES, Paris - FRA VA-ECMO for cardiogenic shock A. GERSHLICK, Leicester - UK Update on ECMONet projects D. BRODIE, New York - USA

K 10.30 - 11.00 Coffee Break

11.00 - 12.30 CARDIOGENIC SHOCK 2018 UPDATE

Chairmen: A. COMBES, Paris - FRA – H. THIELE, Leipzig - GER

The latest ESC guidelines for STEMI: implications for the care of acute cardiogenic shock patients H. THIELE, Leipzig - GER

Frenshock registry data C. DELMAS, Toulouse - FRA What is the drug of choice in 2018? B. LEVY, Nancy - FRA Biomarkers… beyond natriuretic peptides A. MEBAZAA, Paris - FRA MRI for disease diagnosis A. REDHEUIL, Paris - FRA

12.45 - 13.45 Lunch symposium (more details page 8)

14.00 - 15.30 ECCO2R

Chairmen: A. COMBES, Paris - FRA – C. KARAGIANIDIS, Koeln - GER

Clinical consequences of Hypercapnia A. DESSAP, Paris - FRA SUPERNOVA pilot trial results… And now? M. RANIERI, Rome - ITA The latest about ECCO2R for COPD patients C. KARAGIANIDIS, Koeln - GER ECCO2R for COPD: the vent-AVOID trial and beyond D. BRODIE, New York - USA

K 15.30 - 16.00 Coffee Break

16.00 - 17.30 TCS IN THE CATH-LAB

Chairmen: N. BRECHOT - C. SPAULDING, Paris - FRA

Catheter based TCS, an update of Impella and PHP results D. DUDEK, Krakow - POL High risk PCI: need for TCS support?

∙ No: French Experience J.-P. COLLET, Paris - FRA∙ Yes: German/US Experiences M. SINNING, Bonn - GER∙ Which device, if any? Choice Impella 2.5/CP vs VA-ECMO C. SPAULDING, Paris - FRA

Panel discussion: should we combine two devices in the same patient?

5 w w w . t c s - e c m o . o r g

THURSDAY 28 JUNE - ROOM 202/203

09.00 - 10.30 ECMO BASICS With simultaneous interpretation

Chairmen: B. LEVY, Nancy - FRA – Chirine MOSSADEGH, Paris - FRA

ECMO Principles Kathleen DALY, London - UK VV ECMO Indications Cara AGERSTRAND, New York - USA VA ECMO Indications B. LEVY, Nancy - FRA Bedside Management Marie-Astrid NION, Angers - FRA

K 10.30 - 11.00 Coffee Break

11.00 - 12.30 ARDS

Chairmen: A. DESSAP, Paris - FRA – E. FAN, Toronto - CAN

Lessons to learn from epidemiology A. DESSAP, Paris - FRA The good and the bad of high PEEP E. FAN, Toronto - CAN What is the ideal target for blood oxygenation in ARDS? K. PALMER, Stockholm - SWE Long term prognosis of ARDS patients E. FAN, Toronto - CAN What is P-SILI? And how can it increase VILI? L. BROCHARD, Toronto - CAN

12.45 - 13.45 Lunch symposium (more details page 8)

14.00 - 15.30 TCS IN STEMI PATIENTS WITH CARDIOGENIC SHOCK

Chairmen: N. BRECHOT - C. SPAULDING, Paris - FRA

Myocardial infarction management: from the 70’s to 2018 C. SPAULDING, Paris - FRA Culprit shock results discussion H. THIELE, Leipzig - GER Management of the AMI patient after PCI and TCS N. BRECHOT, Paris - FRA Is it time for a big RCT in TCS? H. THIELE, Leipzig - GER

K 15.30 - 16.00 Coffee Break

16.00 - 17.30 ETHICS With simultaneous interpretation

Chairmen: Jo Anne FOWLES, London - UK – K. PALMER, Stockholm - SWE

Managing families Cara AGERSTRAND, New York - USA How to manage awake ECMO patients Jo Anne FOWLES, London - UK End of life in Pediatrics Emilie MEURISSE, Paris - FRA Patient testimony

6

FRIDAY 29 JUNE – LIST AND STEPHENSON

09.00 - 10.30 TCS/ECMO IN SPECIFIC SETTINGS

Chairmen: P. LEPRINCE - M. SCHMIDT, Paris - FRA Ablation and rhythmology under TCS-ECMO X. WAINTRAUB, Paris - FRA

∙ Impella vs. ECMO for interventional treatments∙ Arrhythmia treatment in LVAD patients

TCS/ECMO in post cardiotomy cardiogenic shock G. LEBRETON, Paris - FRA TCS for severe RV failure J. JOUAN, Paris - FRA

∙ In which situation? What is the best option in 2018? ECMO to rescue lethal pulmonary embolism M. SCHMIDT, Paris - FRA Impella 5.0 to test RV function prior to LVAD implantation G. LEBRETON, Paris - FRA

K 10.30 - 11.00 Coffee Break

11.00 - 12.30 ECMO VV

Chairmen: A. SLUTSKY, Toronto - CAN – F. TACCONE, Brussels - BEL Prime time results of the EOLIA trial A. COMBES, Paris - FRA ECMO for acute respiratory failure: implications of EOLIA results A. SLUTSKY, Toronto - CAN Optimizing MV in ECMO patients N. FERGUSON, Toronto - CAN Defining the right anticoagulation target Cara AGERSTRAND, New York - USA NeuroMonitoring on VV-ECMO F. TACCONE, Brussels - BEL

12.30 - 13.30 Lunch symposium (more details page 8)

13.45 - 15.15 CARDIAC ARREST AND TCS

Chairmen: J. BELOHLAVEK, Prague - CZE – B. LEVY, Nancy - FRA

Therapeutic hypothermia? Still an option? A. CARIOU, Paris - FRA The latest series of ECMO for refractory cardiac arrest F. TACCONE, Brussels - BEL Out-of-hospital cardiac arrest ECPR controversy

∙ Rush the patient to the Cathlab J. BELOHLAVEK, Prague - CZE∙ Stay and play on the scene L. LAMHAUT, Paris - FRA

K 15.15 - 15.45 Coffee Break

15.45 - 17.15 ETHICAL DILEMMAS IN ECMO/TCS PATIENTS

Chairmen: N. BARRETT, London - UK – D. BRODIE, New York - USA

Integrating palliative care in the non-weanable ECMO patient in the ICU J.R. CURTIS, Washington - USA

Ethical considerations in the donation after cardiac death program C.-E. LUYT, Paris - FRA Withdrawing may be preferable to withholding? N. BARRETT, London - UK Spiritual and palliative care providers D. BRODIE, New York - USA

7

FRIDAY 29 JUNE - ROOM 202/203

09.00 - 10.30 COMPLICATIONS With simultaneous interpretation

Chairmen: Cara AGERSTRAND, New York - USA – Sabine VALERA, Marseille - FRA Specifics of VV ECMO Sabine VALERA, Marseille - FRA Specifics of VA ECMO Chirine MOSSADEGH, Paris - FRA Specifics of Pediatric ECMO Maylis DORENT, Paris - FRA

K 10.30 - 11.00 Coffee Break

11.00 - 12.30 ECMO/TCS ORGANIZATION

Chairmen: N. BARRETT, London - UK – Chirine MOSSADEGH, Paris - FRA Organization of a level-1 ECMO cardiac center: regionalization

and networking in England N. BARRETT, London - UK Should all cathlabs provide TCS?

∙ Yes E. LA SCALA, Ollioules - FRA∙ No C. SPAULDING, Paris - FRA

Practical aspects for centers with no current on-site TCS J. BELOHLAVEK, Prague - CZE∙ Percutaneous insertion possible for all patients? ∙ How to do it? Practical aspects for the interventional cardiologist∙ Which device, pricing implications…

How to set up a simulation program? Chirine MOSSADEGH, Paris - FRA

12.30 - 13.30 Lunch symposium (more details page 8)

13.45 - 15.15 MY IDEAL ECMO PROGRAM With simultaneous interpretation

Chairmen: A. COMBES, Paris - FRA – M. OGINO, Nemours - USA Overview of ECMO nurses worldwide Chirine MOSSADEGH, Paris - FRA How should we organize ECMO nationwide Kathleen DALY, London - UK ELSO Education Curriculum M. OGINO, Nemours - USA

SIMULATIONS WORKSHOPS – ROOM 302 - Limited number of places

6 SESSIONS

Thursday, June 28, 2018: 11.00 – 12.30 / 14.00 – 15.30 / 16.00 – 17.30Friday, June 29, 2018: 09.00 – 10.30 / 11.00 – 12.30 / 13.45 – 15.15There will be two groups of 6 participants who will have 45 minutes of cannulation workshop and 45 minutes of troubleshooting workshop.

WORKSHOP 1 - CANNULATION D. R. MIRANDA, Rotterdam - NED

WORKSHOP 2 - TROUBLESHOOTING La Pitié Salpêtrière team

Emric BESNARD - Hugo GUILLOU - Anne-Sophie LEQUEULX Chirine MOSSADEGH - Sabine VALERA, Paris

Angers team Marie-Astrid NION - M. PIERROT - D. VERRON, Angers

INDUSTRY SYMPOSIUM, HOSTED BY GETINGE

12.45 - 13.45QUO VADIS ECLS? Lunch symposium with the support of GETINGE

Chairmen: A. COMBES, Paris - FRA – D. BRODIE, New York - USA

VA-ECMO will change the outcome of cardiogenic shock in myocardial infarction A. COMBES, Paris - FRA

Which patients should receive ECMO for respiratory failure after EOLIA? D. BRODIE, New York - USA

ExtraCorporeal gas exchange: current and future indications C. KARAGIANIDIS, Koeln - GER

THURSDAY 28 JUNE – LIST AND STEPHENSON

FRIDAY 29 JUNE – LIST AND STEPHENSON

INDUSTRY SYMPOSIUM, HOSTED BY ABIOMED

TCS - ECMO

12.30 - 13.30WHEN TO USE PERCUTANEOUS VENTRICULAR ASSIST DEVICES? Lunch Symposium with the support of Abiomed

Chairman: C. SPAULDING, Paris - FRA

Case discussion: Complex, High Risk PCI D. DUDEK, Krakow - POL

Case discussion: Cardiogenic Shock M. SINNING, Bonn - GER

8

9 w w w . t c s - e c m o . o r g

THANKS TO OUR PARTNERS

SILVER SPONSOR

BRONZE SPONSOR

SUPPORTERS

10

Join our sponsored lunch Symposium - June 28th Quo Vadis ECLS ?

Chairmen: A.Combes and D. Brodie

Time: 12:45 - 13:45

Room: List and Stephenson

Program: VA-ECMO will change the outcome of cardiogenic shock in myocardial infarction A. Combes, Paris

Which patients should receive ECMO for respiratory failure after EOLIA? D. Brodie, New-York

Extracorporeal gas exchange: current and future indications C. Karagianidis, Koeln

Getinge is not responsible for the content of the symposium.

demi-page_pub_TCS_ECMO2018.indd 1 12/06/2018 16:59:44

DEMONSTRATION WORKSHOP IN THE EXHIBITION ON THURSDAY, JUNE 28

with the support of

What is new in ventilation and CO2 monitoring prolonged CPR:

come and test an innovative manikin with CO2 production

THURSDAY, JUNE 28

10.30 - 11.00

12.45 - 13.15

13.15 - 13.45

15.30 - 16.00

Limited places

UC201807563FF Command the Future Advert 105x148,5mm.indd 1 13/06/2018 15:19

12

a

AFKLM Official carriersNº dossier : 2008140E

Date : 03/06/08

Validation DA/DC :

Validation Client :

P296C

P032C

P299C

TCS - ECMO TCS - ECMO INTERNATIONAL CONGRESS

J U N E 28 -292018 P A R I S

16 RUE JEAN REY 75015

UI

CP

CONGRESS VENUE VENUE: UICP - 16 Rue Jean Rey, 75015 Paris - Ph: +33 (0)1 44 49 22 30

LOGISTICS ORGANIZATION AND REGISTRATION OVERCOME: 13-15 rue des Sablons 75116 Paris, France Ph: +33 (0)1 40 88 97 97 - Fax: +33 (0)1 43 59 76 07 E-mail: paris-tcsecmo@overcome.fr

* Proof of status/membership will be required The registration fee includes: access to the scientifi c sessions and the exhibition, daily breaks as well as Congress documents.

CME Accreditation by the EACCME® confers the right to place the following statement in all communication materials including the event website, the event programme and the certifi cate of attendance. The following statements must be used without revision: “The TCS-ECMO, Paris, France, 28/06/2018-29/06/2018 has been accredited by the European Accreditation Council for Continuing Medical Education (EACCME®) with 12 European CME credits (ECMEC®s). Each medical specialist should claim only those hours of credit that he/she actually spentin the educational activity.” “Through an agreement between the Union Européenne des Médecins Spécialistes and the American Medical Association, physicians may convert EACCME® credits to an equivalent number of AMA PRA Category 1 CreditsTM. Information on the process to convert EACCME® credit to AMA credit can be found at www.ama-assn.org/education/earn-credit-participation-international-activities.“Live educational activities, occurring outside of Canada, recognised by the UEMS-EACCME® for ECMEC®s are deemed to be Accredited Group Learning Activities (Section 1) as defi ned by the Maintenance of Certifi cation Program of the Royal College of Physicians and Surgeons of Canada.”

EXHIBITION An exhibition will take place in the heart of the event, hosting industry partners.

ACCOMMODATION Rooms have been reserved for the participants during the event at preferential rates. For information and booking: Ph: +33 (0)1 40 88 97 97 - E-mail : paris-tcsecmohousing@overcome.fr

TRANSPORTATIONEvent: TCS-ECMO Event ID: 32435AFValid for travel from 23/06/2018 to 04/07/2018 Event location: Paris, France Attractive discounts on a wide range of airfares on all Air France and KLM fl ights world-

wide**. Use the website of this event or visit www.airfranceklm-globalmeetings.com to: • access the preferential fares granted for this event* • make your booking • issue your electronic ticket*• select your seat**

If you buy your ticket via AIR FRANCE & KLM Global Meetings website, your electronic ticket will carry a special mention which justifi es the application of the preferential fares. Should you prefer to process your reservations and ticket-purchase directly with an Air France and KLM sales outlet, you must keep this current document, which serves to justify the application of the preferential airfares. Keep the document to justify the special fares with you as you may be asked for it at any point of your journey. Frequent fl yer / loyalty programs of Air France and KLM partner airlines are credited with «miles» when Air France or KLM fl ights are used. * not available in certain countries ** subject to conditions

Train vouchers are available on request from Overcome.

REGISTRATIONS On site

Doctors 520 €

SRLF or ESICM members* 470 €

Nurses, technicians, students* 340 €